Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212795
Company: TENSHI
Company: TENSHI
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LORATADINE | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING;ORAL | Over-the-counter | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/18/2020 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/212795Orig1s000ltr.pdf |
LORATADINE
The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.
TABLET, ORALLY DISINTEGRATING;ORAL; 5MG
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | Application No. | Company |
---|---|---|---|---|---|---|---|
CLARITIN REDITABS | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING;ORAL | Over-the-counter | Yes | 021993 | BAYER HEALTHCARE LLC |
LORATADINE | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING;ORAL | Over-the-counter | No | 212795 | TENSHI |